BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Sep. 23, 2016
View Archived Issues
Canon makes bet on molecular diagnostics with $40M investment in T2 Biosystems
The stock of molecular diagnostics company T2 Biosystems Inc. spiked 10 percent due to a $40 million equity investment from Melville, N.Y.-based Canon U.S.A. Inc., made in return for a nearly 20 percent stake in the firm.
Read More
Shuren says MDUFA IV would add $6 million a year for NEST program
Read More
Observational study predicts reassessment of French coronary stent reimbursement program
Read More
Claret Medical files for FDA clearance of its Sentinel cerberal protection system
Read More
Regulatory Front
Read More
Daily M&A
Read More
Appointments and advancements
Read More
Product briefs
Read More
Financings
Read More
MDD's Diagnostics Extra
Read More
